Your browser doesn't support javascript.
loading
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
Kehrloesser, Sebastian; Oberst, Simon; Westerhuis, Willien; Wendler, Astrid; Wind, Anke; Blaauwgeers, Harriët; Burrion, Jean-Benoit; Nagy, Péter; Saeter, Gunnar; Gustafsson, Eva; De Paoli, Paolo; Lovey, József; Lombardo, Claudio; Philip, Thierry; de Valeriola, Dominique; Docter, Marjet; Boomsma, Femke; Saghatchian, Mahasti; Svoboda, Marek; Philip, Irene; Monetti, Francesco; Hummel, Henk; McVie, Gordon; Otter, Renée; van Harten, Wim.
Affiliation
  • Kehrloesser S; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK.
  • Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Westerhuis W; Cancer Research UK Cambridge Centre, University of Cambridge, UK.
  • Wendler A; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Wind A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK.
  • Blaauwgeers H; Rijnstate Hospital, Arnhem, The Netherlands.
  • Burrion JB; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Nagy P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Saeter G; National Institute of Oncology, Budapest, Hungary.
  • Gustafsson E; Organisation of European Cancer Institutes, Brussels, Belgium.
  • De Paoli P; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Lovey J; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Lombardo C; Alliance Against Cancer, Rome, Italy.
  • Philip T; Organisation of European Cancer Institutes, Brussels, Belgium.
  • de Valeriola D; National Institute of Oncology, Budapest, Hungary.
  • Docter M; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Boomsma F; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Saghatchian M; Institut Curie, Paris Cedex 05, France.
  • Svoboda M; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Philip I; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Monetti F; Rijnstate Hospital, Arnhem, The Netherlands.
  • Hummel H; Radiotherapeutisch Instituut Friesland, Leeuwarden, The Netherlands.
  • McVie G; Institut Gustave Roussy, Villejuif, France.
  • Otter R; American Hospital of Paris, Neuilly-sur-Seine, France.
  • van Harten W; Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Mol Oncol ; 15(5): 1277-1288, 2021 05.
Article in En | MEDLINE | ID: mdl-33734563
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Cancer Care Facilities / Neoplasms Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Cancer Care Facilities / Neoplasms Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: